Format
Sort by

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 57

1.

An open-label study of the tolerability of mixed amphetamine salts in adults with attention-deficit/hyperactivity disorder and treated primary essential hypertension.

Wilens TE, Zusman RM, Hammerness PG, Podolski A, Whitley J, Spencer TJ, Gignac M, Biederman J.

J Clin Psychiatry. 2006 May;67(5):696-702.

PMID:
16841618
2.

Stimulant therapy in the management of ADHD: mixed amphetamine salts (extended release).

Faraone SV.

Expert Opin Pharmacother. 2007 Sep;8(13):2127-34. Review.

PMID:
17714065
3.

Evolution of the treatment of attention-deficit/hyperactivity disorder in children: a review.

Findling RL.

Clin Ther. 2008 May;30(5):942-57. doi: 10.1016/j.clinthera.2008.05.006. Review.

PMID:
18555941
4.
5.

Onset of efficacy of long-acting psychostimulants in pediatric attention-deficit/hyperactivity disorder.

Brams M, Mao AR, Doyle RL.

Postgrad Med. 2008 Sep;120(3):69-88. doi: 10.3810/pgm.2008.09.1909. Review.

PMID:
18824827
6.

Attention-deficit/hyperactivity disorder in adults: evidence-based recommendations for management.

Rostain AL.

Postgrad Med. 2008 Sep;120(3):27-38. doi: 10.3810/pgm.2008.09.1905. Review.

PMID:
18824823
7.

An update on central nervous system stimulant formulations in children and adolescents with attention-deficit/hyperactivity disorder.

Chavez B, Sopko MA Jr, Ehret MJ, Paulino RE, Goldberg KR, Angstadt K, Bogart GT.

Ann Pharmacother. 2009 Jun;43(6):1084-95. doi: 10.1345/aph.1L523. Epub 2009 May 26. Review.

PMID:
19470858
8.

Efficacy and safety limitations of attention-deficit hyperactivity disorder pharmacotherapy in children and adults.

Wigal SB.

CNS Drugs. 2009;23 Suppl 1:21-31. doi: 10.2165/00023210-200923000-00004. Review.

PMID:
19621975
9.

Risk of serious cardiovascular problems with medications for attention-deficit hyperactivity disorder.

Martinez-Raga J, Knecht C, Szerman N, Martinez MI.

CNS Drugs. 2013 Jan;27(1):15-30. doi: 10.1007/s40263-012-0019-9. Review.

PMID:
23160939
10.

Atomoxetine: a review of its use in attention-deficit hyperactivity disorder in children and adolescents.

Garnock-Jones KP, Keating GM.

Paediatr Drugs. 2009;11(3):203-26. doi: 10.2165/00148581-200911030-00005. Review.

PMID:
19445548
11.

Novel treatments for attention-deficit/hyperactivity disorder in children.

Spencer TJ, Biederman J, Wilens TE, Faraone SV.

J Clin Psychiatry. 2002;63 Suppl 12:16-22. Review.

12.

Attention deficit hyperactivity disorder in adults.

Rösler M, Casas M, Konofal E, Buitelaar J.

World J Biol Psychiatry. 2010 Aug;11(5):684-98. doi: 10.3109/15622975.2010.483249. Review.

PMID:
20521876
13.

A qualitative review of issues arising in the use of psycho-stimulant medications in patients with ADHD and co-morbid substance use disorders.

Kollins SH.

Curr Med Res Opin. 2008 May;24(5):1345-57. doi: 10.1185/030079908X280707 . Epub 2008 Apr 1. Review.

PMID:
18384709
14.

Adderall XR: long acting stimulant for single daily dosing.

Sallee FR, Smirnoff AV.

Expert Rev Neurother. 2004 Nov;4(6):927-34. Review.

PMID:
15853519
15.

Drug therapy for adults with attention-deficit hyperactivity disorder.

Wilens TE.

Drugs. 2003;63(22):2395-411. Review.

PMID:
14609347
16.

A review of the pharmacotherapy of adults with attention-deficit/hyperactivity disorder.

Wilens TE, Spencer TJ, Biederman J.

J Atten Disord. 2002 Mar;5(4):189-202. Review.

PMID:
11967475
17.

Amphetamines for Attention Deficit Hyperactivity Disorder (ADHD) in adults.

Castells X, Ramos-Quiroga JA, Bosch R, Nogueira M, Casas M.

Cochrane Database Syst Rev. 2011 Jun 15;(6):CD007813. doi: 10.1002/14651858.CD007813.pub2. Review.

PMID:
21678370
18.

Attention-deficit-hyperactivity disorder: an update.

Dopheide JA, Pliszka SR.

Pharmacotherapy. 2009 Jun;29(6):656-79. doi: 10.1592/phco.29.6.656. Review.

PMID:
19476419
19.

Management of ADHD in adults.

Adler LA, Chua HC.

J Clin Psychiatry. 2002;63 Suppl 12:29-35. Review.

20.

Diagnosis and treatment of ADHD in adults in primary care.

Montano B.

J Clin Psychiatry. 2004;65 Suppl 3:18-21. Review.

Items per page

Supplemental Content

Write to the Help Desk